Table 2

- Clinical presentation, associated diseases, and diabetes ketoacidosis severity (DKA).

ParameterOverall, N=156DKA severityP-value
Mild n=47Moderate n=61Severe, n=8
Diabetes status     
Known73 (47.1%)25 (53.2%)33 (54.1%)15 (31.9%)0.049
New82 (52.9%)22 (46.8%)28 (45.9%)32 (68.1%) 
Season     
Winter34 (21.8%)9 (19.1%)13 (21.3%)12 (25.0%)0.190
Spring28 (17.9%)8 (17.0%)14 (23.0%)6 (12.5%) 
Summer45 (28.8%)11 (23.4%)22 (36.1%)12 (25.0%) 
Autumn49 (31.4%)19 (40.4%)12 (19.7%)18 (37.5%) 
DM duration of known T1DM patients     
Years3.3 ± 2.53.5 ± 2.23.4 ± 2.82.9 ± 2.30.617
Glycemic control of known T1DM patients     
Good1 (1.4%)1 (4.8%)0 (0.0%)0 (0.0%)0.002
Average14 (20.3%)9 (42.9%)5 (15.2%)0 (0%) 
Poor54 (78.3%)11 (52.4%)28 (84.8%)15 (100%) 
Presence of associated chronic disease     
Yes25 (16.0%)9 (19.1%)11 (18.0%)5 (10.4%)0.436
Type of associated chronic disease     
ADHD6 (25.0%)3 (37.5%)2 (18.2%)1 (20.0%)0.829
Autism2 (8.3%)0 (0.0%)1 (9.1%)1 (20.0%)0.682
Celiac disease11 (45.8%)5 (62.5%)4 (36.4%)2 (40.0%)0.561
G6PD deficiency2 (8.3%)0 (0.0%)2 (18.2%)0 (0.0%)0.681
Hypothyroidism4 (16.7%)0 (0.0%)2 (18.2%)2 (40.0%)0.152
Down syndrome1 (4.2%)0 (0.0%)1 (9.1%)0 (0.0%)>0.999
CHD1 (4.2%)0 (0.0%)1 (9.1%)0 (0.0%)>0.999
Nephrotic syndrome1 (4.2%)0 (0.0%)1 (9.1%)0 (0.0%)>0.999
DKA duration     
<24 hrs.k; <24 hours141 (90.4%)47 (100%)57 (93.4%)37 (77.1%)<0.001
24 to 48 hours14 (9.0%)0 (0.0%)4 (6.6%)10 (20.8%) 
>48 hours1 (0.6%)0 (0.0%)0 (0.0%)1 (2.1%) 
  • ADHD: attention deficit hyperactivity disorder, G6PD: glucose-6-phosphate dehydrogenase deficiency, CHD: congenital heart disease, T1DM: type 1 diabetes mellitus